Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Statistics in study were flawed
| The first 150 words of the full text of this article appear below. |
EDITOR
Taylor et al come to the conclusion that their study of
homoeopathy versus placebo in perennial allergic rhinitis "has failed
to confirm our original hypothesis that homeopathy is a placebo."1 Unfortunately, the statistics do not prove that.
The basis for the study was a prestudy power calculation that required 120 patients to prove the hypothesis with a 5% significance and an 80% power.2 In fact, the authors only recruited 51 patients but analysed the results as if they had the required number. Their only conclusion was that they did not have enough data to make a conclusion.
If we accept the availability of only 51 patients at the outset, what
are the relevant calculations? The power calculation is only 43%, and
to maintain the power calculation at 80% the P value becomes 34%. The
only conclusion is that the trial is not able to prove anything.
Competing interests: None declared.
| 1. |
Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison TC.
Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series [with commentary by T Lancaster, A Vickers].
BMJ
2000;
321:
471-476 |
| 2. | Reilly DT, Taylor MA, McSharry C, Aitchison T. Is homoeopathy a placebo response? Controlled trial of homoeopathic potency, with pollen in hayfever as model. Lancet 1986; ii: 881-886. |
Study shows dissociation between objective and subjective responses to homoeopathy in allergic rhinitis
EDITOR
Taylor et al
What can you learn from this BMJ paper? Read Leanne Tite's Paper+